Conference Coverage
Video
CGRP drugs: How is it going?
STOWE, VT. – Dr. Peter McAllister summarizes postmarketing experiences with CGRP monoclonal antibodies for migraine prevention.
Conference Coverage
Migraine associated with more severe disability in patients with MS
DALLAS – “Traditional migraine risk factors such as obesity, anxiety, and depression were also overrepresented in our cohort” of patients with MS...
Conference Coverage
Survey Identifies Variations in Management of Pediatric Posttraumatic Headache
CHICAGO—Child neurologists differ in their approach to diagnosing and managing posttraumatic...
Conference Coverage
Treatment Challenges When Headache Has Central and Peripheral Involvement
ASHEVILLE, NC—Although neurologists tend to classify disorders as problems of either the CNS or the peripheral nervous...
Conference Coverage
Migraine Elevates the Risk of Perioperative Stroke
ASHEVILLE, NC—The 30 days after surgery are a period of exceptionally high...
Conference Coverage
Which Treatments Are Effective Against Intractable Cluster Headache?
ASHEVILLE, NC—Patients with intractable cluster headache present an urgent challenge to neurologists....
Conference Coverage
What Are the Characteristics of Children With Poststroke Headache?
CHICAGO—Among children with pediatric stroke, older age at stroke onset, unilateral infarct location,...
Conference Coverage
Triggers May Guide Treatment of New Daily Persistent Headache
ASHEVILLE, NC—New daily persistent headache is rare and difficult to treat. Although neurologists may be tempted to try...
Conference Coverage
Controlling Estrogen Levels May Treat Menstrual Migraine
ASHEVILLE, NC—Menstrual-related migraine (MRM) can be particularly disabling and is difficult...
Conference Coverage
IV Dihydroergotamine Is Associated With Chest Pain in Pediatric Patients With Headache
CHICAGO—Among pediatric patients who receive IV dihydroergotamine (DHE) for headache, chest pain is a common side effect...